down fat and, thus, counteracts fat accumulation in the liver. If, on other hand, normal mice are treated with cortisol, their HES1 levels in the liver drops, while triglyceride levels rise. Further experiments have shown that the cortisol receptor in this newly found metabolic pathway act directly on a switch of the HES1 gene and, thus, switches it off completely.
"We have discovered a key mechanism here that plays a crucial role in many pathologic metabolic disorders," explains Stephan Herzig. "It has been obvious for some time that there is an association between the body's own cortisol or therapeutically administered cortisone and the development of fatty liver. Now we also know what the interconnections look like at a molecular level."
'/>"/>
Page: 1 2 Related biology news :1.
Omega-3 fatty acids protect against Parkinsons, study says2.
University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels3.
Typical North American diet is deficient in omega-3 fatty acids4.
Trans-fatty acids and insulin sensitivity5.
Scientists suspect omega-3 fatty acids could slow acute wound healing6.
Atomic structure of the mammalian fatty acid factory determined7.
Researchers identify proteins involved in new neurodegenerative syndrome8.
Texas researchers and educators head for Antarctica9.
MGH researchers describe new way to identify, evolve novel enzymes10.
University of Pennsylvania researchers develop formula to gauge risk of disease clusters11.
U of MN researchers discover noninvasive diagnostic tool for brain diseases